Medtronic EVP & President Hooman Hakami to Speak at Oppenheimer Healthcare Conference

On March 13, 2018 Medtronic plc (NYSE:MDT), the global leader in medical technology, reported it will participate in the Oppenheimer 28th Annual Healthcare Conference on Tuesday, March 20, 2018, in New York City (Press release, Medtronic, MAR 13, 2018, View Source;p=RssLanding&cat=news&id=2337864 [SID1234524735]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Hooman Hakami, executive vice president and group president of Medtronic’s Diabetes Group, will answer questions about the company beginning at 8:35 a.m. EDT (7:35 a.m. CDT).

A live audio webcast of the presentation will be available on March 20, 2018, by clicking on the Investor Events link at View Source An archive of the session will be available on the same webpage later in the day.